Cell type expertise that moves manufacturing forward.

We’ve mastered the intricate and interrelated processes required to ensure your cells function as intended as you scale faster. 

Group 35381

GMP cell manufacturing optimized for every cell type.

We have benchmark industry experience taking an iPSC and successfully differentiating it into your targeted cell type, ensuring that new iPSC cells generated at scale look and behave exactly as intended. It’s the kind of undertaking that requires peerless capabilities in process design and optimization, analytical development, quality control and assurance, and product release. 

No matter your desired cell function, our customizable offering supports the development path you need to efficiently move your medicine forward. 


Accelerate Icon

Accelerate speed to clinic 

With Echo™, our  pre-established, iPSC-based GMP manufacturing platform 

Gear Icon

Reduce process & analytical development challenges

With pre-built platform and ready-to-use starting materials (including our Allo Chassis™ or unedited master cell banks) 

Idea Icon

Secure clear IP positioning and licensing framework

With Allo Chassis™, STAR-CRISPR™, and a strong Cellistic patent estate that safeguards methods, edits, and manufacturing

Document Icon

Ensure regulatory readiness & GMP compliance

With our GMP platform and EMA-certified, FDA and PMDA-compliant manufacturing facility

Priming your cell therapy program to fulfill its full potential.

We’ve put our expertise in iPSCs into action by creating platforms and enabling technologies that leverage the “80/20 rule.” With a manufacturing process that uses largely pre-built components, we not only streamline operations — we sharpen our focus on the distinct details of your cell therapy that matter most.

Echo™-NK

A plug-and-play, high-yield platform for iPSC-NK manufacturing built to deliver a strategic advantage through lower COGs, broader patient access, and greater investor confidence.

Echo™-Cardio

An industrialized, end-to-end GMP manufacturing platform that delivers clinical grade, high-purity iPSC-derived cardiomyocytes at therapeutic scale, accelerating your path to the clinic.

Echo™-Endothelial  

Overcomes notoriously hard scaling challenges that max out at 30% purity to deliver ~90% lineage specificity and a fully GMP-ready workflow.

Echo™-TCell

Echo™-TCell unlocks the potential of allogeneic T-cell therapies – including α/β  T cells and  Tregs – by generating engineered iPSC-T cells designed for potency, persistence, and safety at scale.

Group 35338-1

Easier said than done? Let’s see. 

Start with a cell. Expand it. Differentiate it. Expand it again — with no changes from beginning to end. Four seemingly simple steps that come with a nearly endless cascade of decisions that can make the difference between success and failure. We’ve mastered those steps. Let’s talk about how you can use that experience to your advantage.